Hedgehog signaling

Hedgehog signaling
Name	Hedgehog signaling
Organism	Drosophila
Discovered	1980s
Components	Protein kinase A, Smoothened, Patched, GLI1, Sonic Hedgehog

Hedgehog signaling is a conserved intercellular communication cascade originally characterized in Drosophila genetic screens and later shown to operate in Mus musculus and humans. It coordinates cell fate, proliferation, and pattern formation during Embryogenesis and organogenesis, and its dysregulation is implicated in developmental disorders and cancers such as Basal cell carcinoma and Medulloblastoma. Research on the pathway intersects with studies from institutions like the Max Planck Society, Harvard University, and the National Institutes of Health.

Overview

Hedgehog signaling was revealed through classical genetic work by researchers associated with labs at Columbia University, University of Cambridge, and Cold Spring Harbor Laboratory that used mutagenesis screens in Drosophila melanogaster and comparative studies in Zebrafish and Mouse knockout models. The pathway links extracellular morphogen gradients to transcriptional responses mediated by zinc-finger factors related to GLI1 and interacts functionally with pathways studied at Stanford University and the Broad Institute. Developmental biology conferences at venues like the Society for Developmental Biology frequently feature work on ligand diffusion, receptor modulation, and ciliary trafficking. Core conceptual advances were recognized by prizes awarded by organizations such as the Lasker Award and the Nobel Prize committees for related developmental signaling discoveries.

Components and Molecular Mechanism

Key molecular players include ligands encoded by genes such as Sonic hedgehog, Indian hedgehog, and Desert hedgehog, the twelve-pass transmembrane receptor Patched, the seven-transmembrane protein Smoothened that resembles G protein–coupled receptors studied in Nobel laureate-associated pharmacology, and the zinc-finger transcription factors GLI1, GLI2, and GLI3. Signal transduction involves ligand secretion, interaction with extracellular matrix components explored at Carnegie Institution for Science, endocytic trafficking examined in work from MIT, and primary cilium dynamics characterized by groups at Johns Hopkins University. Post-translational modifications such as cholesterol and palmitoylation on ligands were elucidated in studies linked to Karolinska Institutet and biochemical work in labs at University of California, San Francisco. Intracellular modulation includes phosphorylation by kinases like Protein kinase A, ubiquitination involving E3 ligases studied at Cold Spring Harbor Laboratory, and proteolytic processing influenced by complexes investigated at European Molecular Biology Laboratory.

Role in Embryonic Development and Patterning

During vertebrate neural tube patterning, graded concentrations of Sonic hedgehog from the notochord and floor plate specify ventral neuronal subtypes, an axis of research pursued at University College London and UCSF. Hedgehog-dependent morphogenesis directs limb patterning with experiments performed at Imperial College London and ETH Zurich elucidating digit identity and anterior-posterior polarity. Roles in organogenesis include branching morphogenesis in the lung and pancreas, with translational developmental biology groups at University of Toronto and Seoul National University contributing to the literature. Comparative embryology in models such as Xenopus and Chick embryo helped map evolutionary conservation and divergence of pathway outputs highlighted in symposia at the European Society of Developmental Biology.

Regulation and Crosstalk with Other Pathways

Hedgehog signaling is modulated by interactions with pathways including the Wnt signaling pathway, Notch signaling pathway, and TGF-β networks; collaborative research from Yale University and Princeton University has detailed synergistic and antagonistic relationships. Crosstalk with receptor tyrosine kinase pathways characterized at Cold Spring Harbor Laboratory and metabolic regulation studies from ETH Zurich show integration with PI3K-Akt signaling pathway and energy-sensing networks. Cell biological regulation involves endosomal sorting and primary cilium trafficking described by investigators at Max Planck Institute and University of Oxford, and chromatin-level control connecting to transcriptional regulators studied at Broad Institute and Howard Hughes Medical Institute laboratories.

Involvement in Disease and Cancer

Aberrant activation contributes to tumorigenesis in Basal cell carcinoma, Medulloblastoma, and some Pancreatic cancer subtypes; clinical and genomic analyses from consortia involving the National Cancer Institute and The Cancer Genome Atlas have cataloged pathway alterations. Germline mutations in pathway genes cause congenital disorders such as Gorlin syndrome and craniofacial malformations documented by clinical genetics groups at Mayo Clinic and Great Ormond Street Hospital. Viral oncogenesis research at Fred Hutchinson Cancer Research Center and immuno-oncology studies at Dana-Farber Cancer Institute examine non-cell-autonomous effects of pathway misregulation. Biomarker efforts led by teams at Johns Hopkins Hospital and pharmacoepidemiology work at University of Pennsylvania assess prognostic and predictive implications of pathway activation.

Therapeutic Targeting and Inhibitors

Drug discovery programs at pharmaceutical companies like Genentech, Pfizer, and Novartis produced small-molecule inhibitors targeting Smoothened (e.g., agents advanced in clinical trials run by centers such as Mayo Clinic and MD Anderson Cancer Center). Resistance mechanisms involving secondary mutations and pathway reactivation were characterized through collaborations with the European Organisation for Research and Treatment of Cancer and academic teams at Dana-Farber and Memorial Sloan Kettering Cancer Center. Emerging strategies include targeting downstream transcriptional effectors identified in studies at Scripps Research and exploiting synthetic-lethality approaches investigated at Cold Spring Harbor Laboratory. Ongoing translational research at institutions like Stanford Cancer Institute and regulatory assessments by agencies such as the Food and Drug Administration guide clinical application and safety monitoring.

Category:Signal transduction